# Pressure Ulcers Treatment Market

> Pressure Ulcers Treatment Market Research Report: Size, Share, Trend Analysis By Product Type (Dressings, Topical Agents, Wound Care Devices, Hydrogels, Therapeutic Beds), By Treatment Method (Surgical, Conservative, Pharmacological, Physical Therapy), By End Users (Hospitals, Homecare Settings, Long-term Care Facilities, Others), By Applications (Hospice Care, Acute Care, Rehabilitative Care) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.24%
- **2024:** $ 3.17 Billion
- **2025:** $ 3.27 Billion
- **2035:** $ 4.5 Billion
- **Key Players:** Smith & Nephew (GB), Mölnlycke Health Care (SE), Hollister Incorporated (US), 3M Company (US), KCI Medical (US), Medtronic (IE), Convatec Group (GB), Acelity (US), Derma Sciences (US)

**Report ID:** MRFR/HC/41703-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/pressure-ulcers-treatment-market-43369

---

## Market Summary

## ** Pressure Ulcers Treatment Market Overview**

As per MRFR analysis, the Pressure Ulcers Treatment Market Size was estimated at 3.07 (USD Billion) in 2023. The Pressure Ulcers Treatment Market Industry is expected to grow from 3.17(USD Billion) in 2024 to 4.5 (USD Billion) by 2035. The Pressure Ulcers Treatment Market CAGR (growth rate) is expected to be around 3.24% during the forecast period (2025 - 2035).

### **Key Pressure Ulcers Treatment Market Trends Highlighted**

The pressure ulcer treatment market is primarily driven by the rising prevalence of chronic diseases, particularly among aging populations. With increasing instances of obesity, diabetes, and mobility restrictions, healthcare providers are focusing on better management strategies to address this issue. Healthcare reforms and an increased awareness of wound care are also propelling the adoption of advanced treatments and technologies.

Furthermore, the growing demand for patient-centered care encourages the development of innovative products tailored to individual needs, promoting faster healing and enhancing the quality of life for patients.Opportunities within the market are abundant as advancements in technology present new avenues for effective treatment solutions. The rise in telehealth services and remote monitoring allows providers to track the healing process closely, thereby improving patient outcomes.

There is also potential for developing biocompatible and smarter wound dressings that can assist in healing while minimizing discomfort. The increasing investment in research and development activity also paves the way for innovative therapies that integrate various treatment modalities, allowing for a more comprehensive approach to pressure ulcer management. Recently, trends such as increased use of regenerative medicines and cellular therapies have emerged as exciting new options in the treatment spectrum.The integration of artificial intelligence in managing wound care decisions is also gaining popularity, promoting more accurate assessments and better treatment plans.

Additionally, there is an emphasis on educational initiatives to train healthcare personnel in effective prevention and treatment strategies, which reflects a broader awareness of pressure ulcer management as a priority in healthcare systems. Overall, the market is evolving rapidly, offering various innovative pathways for addressing pressure ulcers effectively.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Pressure Ulcers Treatment Market Drivers**

### **Increasing Prevalence of Pressure Ulcers**

The Pressure Ulcers Treatment Market Industry is experiencing substantial growth driven primarily by the increasing prevalence of pressure ulcers. These are localized injuries to the skin and/or underlying tissue that result from prolonged pressure, often observed in patients with limited mobility, the elderly, and those undergoing surgical procedures. The demographic shift towards an aging population is a significant factor, as older adults are particularly susceptible to developing pressure ulcers due to factors such as decreased skin elasticity, poor circulation and the presence of chronic illnesses.

Furthermore, the rise in chronic conditions such as diabetes and cardiovascular diseases has also contributed to the increased risk of pressure ulcer development. This creates a demand for effective treatments and management options within the Pressure Ulcers Treatment Market Industry, leading to innovations in medical devices, advanced wound care products, and treatment protocols.

Hospitals, long-term care facilities, and home healthcare settings are prioritizing the prevention and treatment of pressure ulcers to improve patient outcomes and quality of life.With healthcare providers and patients becoming more conscious of the issue, there are efforts towards having better preventive measures and treatment options, propelling the market further.

### **Technological Advancements in Treatment Solutions**

Technological advancements are significantly influencing the Pressure Ulcers Treatment Market Industry. The introduction of innovative treatment solutions, such as advanced wound dressings and pressure-relieving equipment, has improved patient care and outcomes. For instance, the development of smart wound dressings equipped with sensors for monitoring healing and the use of dynamic support surfaces can help reduce tissue ischemia. These innovations facilitate faster recovery times and reduce the risk of complications related to pressure ulcers, thus boosting demand within the market.

### **Government Initiatives and Funding for Pressure Ulcer Management**

Government initiatives aimed at improving healthcare outcomes play a crucial role in the growth of the Pressure Ulcers Treatment Market Industry. Various healthcare systems are implementing programs to raise awareness about pressure ulcer prevention and management. Increased funding and resources allocated for the education and training of healthcare professionals on best practices further enhance the quality of care. Such initiatives encourage healthcare facilities to adopt advanced treatment options, thus advancing overall market growth.

## **Pressure Ulcers Treatment Market Segment Insights:**

### **Pressure Ulcers Treatment Market Product Type Insights**

The Pressure Ulcers Treatment Market has shown a diverse array of products categorized under the Product Type segment, which includes Dressings, Topical Agents, Wound Care Devices, Hydrogels, and Therapeutic Beds. The revenue generated from Dressings stands at 1.25 USD Billion in 2024, and it is expected to increase to 1.75 USD Billion by 2035, indicating its dominance and major contributor status in the market.

Dressings are critical as they provide a protective layer over the wound and promote healing, making them essential in the management of pressure ulcers.Topical Agents, valued at 0.65 USD Billion in 2024 and projected to reach 1.0 USD Billion by 2035, also highlight their significance. These agents play a vital role in preventing infection and promoting the healing process, thus driving their market growth. Wound Care Devices, valued at 0.85 USD Billion in 2024, are expected to grow to 1.25 USD Billion by 2035. These devices facilitate efficient treatment and monitoring of pressure ulcers, making them integral to patient care.

Hydrogels, although smaller in valuation, are gaining traction, with a market size of 0.37 USD Billion in 2024, projected to grow to 0.55 USD Billion by 2035, showcasing their importance in maintaining a moist environment conducive to healing.

Finally, Therapeutic Beds, valued at 0.05 USD Billion in 2024 and anticipated to rise to 0.15 USD Billion by 2035, represent a niche yet crucial segment of the market. Their primary function is to reduce pressure on vulnerable areas, thereby preventing the incidence of new ulcers. Overall, the segmentation within the Pressure Ulcers Treatment Market illustrates a balanced distribution of values, with Dressings holding a majority share but all product types contributing to addressing the urgent healthcare need of managing pressure ulcers effectively.

The increasing elderly population and prevalence of chronic diseases are primary drivers for market growth, while challenges include the high cost of advanced treatment options and the need for proper training among healthcare professionals. Nevertheless, the overall market presents ample opportunities for product innovation and expansion, especially in the development of more effective and user-friendly treatment modalities. This diverse product range reflects the extensive landscape within the Pressure Ulcers Treatment Market, underscoring the importance of each segment in delivering comprehensive care to patients with pressure ulcers..

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Pressure Ulcers Treatment Market Treatment Method Insights**

This market segment encompasses different approaches such as Surgical, Conservative, Pharmacological, and Physical Therapy, each playing a crucial role in managing pressure ulcers. Surgical treatments tend to dominate this segment due to their effectiveness in severe cases where other methods are insufficient. Conservative methods, focusing on wound care and pressure relief, also hold a significant share, catering to patients who require less invasive solutions.Pharmacological treatments provide essential support by addressing infections and promoting healing, reflecting trends in pharmaceutical advancements.

Furthermore, Physical Therapy, aimed at rehabilitation and prevention strategies, is gaining traction as healthcare professionals recognize its value in enhancing mobility and reducing recurrence rates. The combination of these treatment methods illustrates a comprehensive approach to the Pressure Ulcers Treatment Market, reflecting the ongoing developments in technology and patient care, showcasing a robust potential for growth and adaptation within the industry.The alignment of various methods is essential for a multi-faceted treatment strategy, responding to diverse patient needs in this evolving healthcare landscape.

### **Pressure Ulcers Treatment Market End User Insights**

The Pressure Ulcers Treatment Market revenue reflects a diverse landscape across various end users, contributing to the overall market growth. Hospitals are often the primary setting, providing specialized care for acute cases of pressure ulcers, while Homecare Settings are gaining traction as more patients receive treatment in comfort, thereby accommodating the growing elderly population.Long-term Care Facilities also maintain a steady presence, addressing chronic conditions requiring ongoing management.

Each end user plays a crucial role in the comprehensive framework of the Pressure ulcer treatment Market industry, with the majority of the treatment services being concentrated in hospitals due to their advanced medical resources. As market dynamics shift, the increasing preference for Homecare Settings reflects changing patient preferences and the desire for personalized care, thus presenting new opportunities in the Pressure Ulcers Treatment Market segmentation.

The market statistics reflect significant growth drivers centered around technological advancements and increased awareness of pressure ulcer prevention, while challenges related to resource allocation and trained personnel remain pivotal. Nonetheless, the multifaceted nature of the end-user segment is poised for sustained development, influenced by innovations in treatment modalities and patient-centric care approaches.

### **Pressure Ulcers Treatment Market Application Insights**

The Application segment of the Pressure Ulcers Treatment Market plays a crucial role in the comprehensive care landscape for patients suffering from pressure ulcers. Hospice care is significant as it addresses the comfort and quality of life for terminally ill patients, while acute care represents a vital segment where immediate and intensive medical interventions are required for patients with severe conditions.Rehabilitative care also holds importance, as it aids in the recovery and prevention of further complications in patients who have sustained pressure ulcers.

The growth in these areas is propelled by the rising aging population and the increasing prevalence of chronic diseases, which heighten the need for targeted interventions. Moreover, there are emerging opportunities with advancements in wound care technologies and products, alongside a growing awareness of pressure ulcer management, all of which contribute to the overall market growth. As the Pressure Ulcers Treatment Market continues to expand, the segmentation is expected to evolve, reflecting changing healthcare priorities and patient needs.

### **Pressure Ulcers Treatment Market Regional Insights**

The Pressure Ulcers Treatment Market is witnessing steady growth across its region. North America holds a significant position in this market, valued at 1.37 USD Billion in 2024, reflecting its majority holding due to advanced healthcare infrastructure and increased prevalence of pressure ulcers. Europe follows closely with a valuation of 1.05 USD Billion in 2024, propelled by rising awareness and support for pressure ulcer management.The Asia Pacific (APAC) region, valued at 0.6 USD Billion in 2024, showcases emerging opportunities owing to expanding healthcare facilities and populations requiring management for pressure ulcers.

Meanwhile, South America and the Middle East Africa (MEA) segments are relatively smaller, valued at 0.07 USD Billion and 0.08 USD Billion respectively in 2024, indicating growth potential but lower demand compared to their counterparts. The market growth in these regions is influenced by enhancing healthcare policies, product innovations, and an increasing aging population requiring effective treatment for pressure ulcers, driving the overall trajectory of the Pressure Ulcers Treatment Market revenue.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Pressure Ulcers Treatment Market Key Players and Competitive Insights**

The Pressure Ulcers Treatment Market is characterized by a highly competitive landscape, driven by the increasing prevalence of pressure ulcers among patients, especially in long-term care settings like nursing homes and among bedridden patients. Growing awareness of effective treatment solutions alongside advancements in medical technology has led to numerous companies vying for market share. The market compositions include various treatments ranging from dressings and topical agents to surgical interventions that aim to prevent, manage, and heal pressure ulcers effectively.

Regulatory approvals and collaborations with healthcare facilities present significant opportunities for innovation and diversification of product offerings, enhancing the competitive dynamics within the market.ConvaTec stands out as a key player in the Pressure Ulcers Treatment Market, leveraging its extensive expertise in advanced wound care technologies.

The company's strengths lie in its diversified portfolio of wound care products, including high-quality dressings designed specifically for pressure ulcers. ConvaTec’s commitment to research and development fosters a continuous flow of innovative solutions, enhancing its market presence. Additionally, the company has established a strong global footprint through strategic partnerships and collaborations with healthcare professionals, ensuring its products meet the evolving needs of patients and providers alike.

The brand’s reputation for product efficacy has cultivated lasting relationships with healthcare providers, further solidifying its competitive advantage in the market.Tegaderm focuses on providing innovative solutions for wound healing, specifically within the Pressure Ulcers Treatment Market, harnessing advanced materials to facilitate moisture management and promote healing. Known for its transparent film dressings, Tegaderm enhances visibility of the wound site while providing a protective barrier against external contaminants.

The product line's adaptability enables use across various care settings and patient populations, which makes it a versatile choice for clinicians. Tegaderm's commitment to quality and efficacy, along with a dedicated approach to meeting patient needs, positions it favorably in the market. The continuous emphasis on consumer education and training for medical professionals regarding proper wound management further strengthens its position, allowing Tegaderm to remain competitive amidst a growing field.

### **Key Companies in the Pressure Ulcers Treatment Market Include:**

- ConvaTec
- Tegaderm
- Angelini Pharma
- Acelity
- Fresenius Kabi
- Essity
- **[Coloplast](https://www.coloplastprofessional.co.uk/education-library/knowledge/advanced-wound-care-knowledge/wound-types/pressure-ulcers/)**
- Smith and Nephew
- Hollister
- 3M
- HillRom
- Cardinal Health
- Medtronic
- Systagenix

## Pressure Ulcers Treatment Market Industry Developments

- **Q2 2024: Smith+Nephew launches new PICO 7Y negative pressure wound therapy system in the US** Smith+Nephew announced the US launch of its PICO 7Y system, a new negative pressure wound therapy device designed to help treat pressure ulcers and other complex wounds. The device features extended wear time and improved portability for patients.
- **Q2 2024: Mölnlycke opens new $50 million wound care manufacturing facility in the US** Mölnlycke, a global leader in wound care, inaugurated a new manufacturing facility in the United States to expand production of advanced dressings for pressure ulcer treatment, aiming to meet growing demand in North America.
- **Q2 2024: Coloplast acquires Kerecis for $1.3 billion to expand wound care portfolio** Coloplast completed the acquisition of Kerecis, an Icelandic company specializing in fish-skin-based wound care products, strengthening its offerings in the pressure ulcer and chronic wound treatment market.
- **Q3 2024: FDA clears 3M’s new Tegaderm Advanced Foam Dressing for pressure ulcer management** The US Food and Drug Administration granted clearance to 3M for its Tegaderm Advanced Foam Dressing, designed to manage exudate and protect against pressure ulcers in at-risk patients.
- **Q3 2024: Convatec appoints Karim Bitar as new CEO to drive wound care innovation** Convatec announced the appointment of Karim Bitar as Chief Executive Officer, with a mandate to accelerate innovation and growth in the company’s wound and pressure ulcer care business.
- **Q3 2024: Medline and Hillrom announce partnership to co-develop smart support surfaces for pressure ulcer prevention** Medline and Hillrom entered a strategic partnership to jointly develop and commercialize advanced support surfaces with integrated sensors for early detection and prevention of pressure ulcers in hospital settings.
- **Q4 2024: Acelity launches new wound care education initiative for pressure ulcer prevention** Acelity, a leader in advanced wound care, launched a global education program aimed at training healthcare professionals in best practices for pressure ulcer prevention and treatment.
- **Q4 2024: Smith+Nephew receives CE mark for RENASYS EDGE negative pressure wound therapy system** Smith+Nephew announced it has received CE mark approval for its RENASYS EDGE system, expanding its portfolio of negative pressure wound therapy devices for pressure ulcer management in Europe.
- **Q1 2025: Urgo Medical secures €100 million funding to expand pressure ulcer treatment R&D** Urgo Medical raised €100 million in new funding to accelerate research and development of advanced wound care solutions, with a focus on pressure ulcer treatment technologies.
- **Q1 2025: Smith+Nephew acquires US-based wound care startup HealX for $200 million** Smith+Nephew acquired HealX, a US-based startup specializing in digital wound assessment tools, to enhance its digital health capabilities in pressure ulcer management.
- **Q2 2025: FDA approves Mölnlycke’s Mepilex Border Flex Lite for pressure ulcer prevention** The FDA approved Mölnlycke’s Mepilex Border Flex Lite, a new dressing designed to prevent and treat pressure ulcers, expanding the company’s advanced wound care portfolio in the US market.
- **Q2 2025: Coloplast opens new innovation center focused on pressure ulcer solutions in Denmark** Coloplast inaugurated a new innovation center in Denmark dedicated to developing next-generation products for pressure ulcer prevention and treatment.

## **Pressure Ulcers Treatment Market Segmentation Insights**

### **Pressure Ulcers Treatment Market****Product Type****Outlook**

- Dressings
- Topical Agents
- Wound Care Devices
- Hydrogels
- Therapeutic Beds

### **Pressure Ulcers Treatment Market****Treatment Method****Outlook**

- Surgical
- Conservative
- Pharmacological
- Physical Therapy

### **Pressure Ulcers Treatment Market****End User****Outlook**

- Hospitals
- Homecare Settings
- Long-term Care Facilities
- Others

### **Pressure Ulcers Treatment Market****Application****Outlook**

- Hospice Care
- Acute Care
- Rehabilitative Care

### **Pressure Ulcers Treatment Market****Regional****Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Increased Awareness and Education

Growing awareness regarding pressure ulcers and their prevention is a significant driver for the Pressure Ulcers Treatment Market. Educational initiatives aimed at healthcare professionals and caregivers have led to improved understanding of risk factors and management strategies. This heightened awareness is reflected in the increasing demand for training programs and resources focused on pressure ulcer prevention and treatment. As healthcare systems prioritize patient safety and quality of care, the emphasis on education is expected to drive market growth. Furthermore, the integration of pressure ulcer management protocols into clinical practice guidelines is likely to enhance the visibility of the Pressure Ulcers Treatment Market.

### Advancements in Medical Technology

Technological innovations play a crucial role in shaping the Pressure Ulcers Treatment Market. The development of advanced [wound care](https://www.marketresearchfuture.com/reports/wound-care-market-926) products, such as hydrocolloid dressings, negative pressure wound therapy, and bioengineered skin substitutes, has revolutionized treatment approaches. These innovations not only enhance healing rates but also improve patient comfort and outcomes. The market for advanced wound care is projected to grow significantly, with estimates suggesting a compound annual growth rate of over 6% in the coming years. As healthcare providers increasingly adopt these technologies, the Pressure Ulcers Treatment Market is likely to experience substantial growth driven by enhanced treatment options.

### Government Initiatives and Funding

Government initiatives aimed at improving healthcare quality and patient outcomes are influencing the Pressure Ulcers Treatment Market. Various health authorities are implementing policies to reduce the incidence of pressure ulcers, which often result in increased healthcare costs and extended hospital stays. Funding for research and development of new treatment modalities is also on the rise, as governments recognize the need for effective solutions. For instance, initiatives that promote the use of evidence-based practices in wound care are likely to enhance the overall treatment landscape. Such supportive measures are expected to bolster the Pressure Ulcers Treatment Market in the foreseeable future.

### Rising Incidence of Pressure Ulcers

The increasing prevalence of pressure ulcers is a primary driver for the Pressure Ulcers Treatment Market. Factors such as an aging population, rising rates of chronic diseases, and prolonged hospital stays contribute to this trend. According to recent estimates, approximately 2.5 million individuals in the United States develop pressure ulcers annually, highlighting the urgent need for effective treatment solutions. This growing patient population necessitates advancements in treatment modalities, thereby propelling market growth. Healthcare providers are increasingly focusing on innovative therapies and products to address this pressing issue, which is expected to further stimulate demand within the Pressure Ulcers Treatment Market.

### Growing Demand for Home Healthcare Services

The shift towards [home healthcare](https://www.marketresearchfuture.com/reports/home-healthcare-market-2030) services is emerging as a key driver for the Pressure Ulcers Treatment Market. As patients increasingly prefer receiving care in the comfort of their homes, there is a rising demand for effective pressure ulcer management solutions tailored for home use. This trend is particularly evident among the elderly population, who are at a higher risk for pressure ulcers. The market for home healthcare products, including specialized mattresses and wound care supplies, is projected to expand significantly. Consequently, the Pressure Ulcers Treatment Market is likely to benefit from this growing demand, as providers develop innovative solutions to cater to home care needs.

## Future Outlook

The Pressure Ulcers Treatment Market is projected to grow at a 3.24% CAGR from 2025 to 2035, driven by technological advancements, increasing geriatric population, and rising healthcare expenditure.

**New opportunities:**

- Development of advanced wound care dressings with antimicrobial properties. Integration of telehealth solutions for remote patient monitoring. Expansion of training programs for healthcare professionals on pressure ulcer prevention.

By 2035, the market is expected to exhibit robust growth, reflecting evolving treatment methodologies and increased awareness.

## Segment Insights

### By Product Type: Dressings (Largest) vs. Wound Care Devices (Fastest-Growing)

The Pressure Ulcers Treatment Market displays a diverse range of product types, with dressings taking the lead as the largest segment. This segment's dominance is attributed to the increased prevalence of pressure ulcers and a growing focus on patient care standards. Dressings account for the majority market share, driven by their importance in maintaining a moist wound environment and promoting faster healing. In contrast, wound care devices are emerging as the fastest-growing segment due to advancements in technology and increased adoption of innovative therapeutic options. Factors contributing to this growth include heightened awareness of pressure ulcers, advancements in wound management technologies, and a shift towards integrated care solutions that encompass these devices alongside traditional treatments.

Dressings (Dominant) vs. Therapeutic Beds (Emerging)

Dressings hold a dominant position in the Pressure Ulcers Treatment Market due to their versatility and effectiveness in treating various wound types. They encompass a wide array of products, including foam dressings, hydrocolloids, and alginates, each offering unique benefits depending on the wound's characteristics. The increasing recognition of pressure ulcers in healthcare settings further solidifies the demand for dressings. On the other hand, therapeutic beds are an emerging segment that enhances patient comfort and aids in pressure redistribution. These beds utilize advanced technologies, such as pressure mapping and dynamic overlays, to prevent the occurrence of pressure ulcers. As healthcare providers increasingly focus on preventative measures, the adoption of therapeutic beds is anticipated to rise.

### By Treatment Method: Surgical (Largest) vs. Pharmacological (Fastest-Growing)

In the Pressure Ulcers Treatment Market, the 'Surgical' treatment method maintains the largest share due to its extensive application in severe cases of pressure ulcers. Surgical interventions, including debridement and flap surgeries, are preferred as they provide immediate relief and promote healing by addressing the underlying tissue damage. In contrast, 'Conservative' and 'Physical Therapy' methods have a lesser market presence, focusing more on supportive care and rehabilitation rather than direct surgical intervention. 'Pharmacological' treatment is witnessing a growing market share as wound healing agents, such as topical antibiotics and growth factors, gain popularity due to their effectiveness in managing infections and accelerating recovery.

Surgical (Dominant) vs. Physical Therapy (Emerging)

The 'Surgical' treatment for pressure ulcers is considered dominant within the treatment modality due to its ability to yield rapid and effective results, particularly in advanced stages of ulcer development. Surgical options facilitate the removal of necrotic tissue and the restoration of healthy blood flow to affected areas, significantly reducing healing times. On the other hand, 'Physical Therapy' is an emerging segment that takes a holistic approach by including exercises and mobility training to prevent further ulceration. While it currently plays a supportive role in treatment protocols, its importance is growing as an adjunct to surgical and pharmacological measures, emphasizing rehabilitation and the improvement of patients' quality of life.

### By End User: Homecare Settings (Largest) vs. Hospitals (Fastest-Growing)

In the Pressure Ulcers Treatment Market, the distribution among the end user segments shows a significant prominence of homecare settings, which dominate the market with a substantial share. This segment benefits from an increasing number of patients opting for at-home care due to convenience and a focus on personalized treatment. Hospitals also play a critical role, holding a considerable share of the market as they cater to acute care scenarios, especially for complex cases of pressure ulcers requiring immediate medical attention. Growth trends indicate that the homecare segment will continue to thrive as the population ages and the demand for effective home treatments rises. Meanwhile, hospitals are witnessing fast growth fueled by advancements in healthcare technologies and patient management systems aimed at improving the quality of care. Increased awareness regarding pressure ulcers is also triggering more hospital admissions, thereby bolstering their market share further.

Homecare Settings (Dominant) vs. Long-term Care Facilities (Emerging)

Homecare settings represent the dominant player in the Pressure Ulcers Treatment Market, characterized by their focus on delivering patient-centered care in familiar environments. This segment largely benefits from the growing trend of personalized healthcare, with many patients preferring to receive treatment at home due to comfort and convenience. Innovations in telehealth and remote monitoring have further enhanced the efficacy of at-home care. Conversely, long-term care facilities are an emerging segment, gaining traction as they provide comprehensive care for individuals with chronic conditions. These facilities are increasingly adopting advanced pressure ulcer treatment protocols and technologies, such as specialized mattresses and skin care products, making them a critical part of the healthcare system in managing pressure ulcers for residents.

### By Application: Hospice Care (Largest) vs. Acute Care (Fastest-Growing)

In the Pressure Ulcers Treatment Market, the application segments are diverse, with Hospice Care commanding the largest share. This segment has seen a stable demand due to the increasing number of patients requiring long-term care and the rising prevalence of pressure ulcers among the elderly population. In contrast, Acute Care, while currently smaller in market share, is rapidly gaining traction as healthcare facilities emphasize immediate and effective treatment solutions for pressure ulcers, particularly in hospital settings. Overall, Rehabilitative Care also plays a significant role, but it does not match the market presence of Hospice Care or the growth potential of Acute Care. The shift towards a patient-centric model, along with innovations in wound care technologies, is expected to further influence the growth dynamics within these segments over the forecast period.

Hospice Care (Dominant) vs. Acute Care (Emerging)

Hospice Care is recognized as the dominant segment in the Pressure Ulcers Treatment Market, attributed to its focus on caring for terminally ill patients who require specialized interventions for pressure sore management. This segment benefits from a strong support framework and a growing recognition of palliative care principles. On the other hand, Acute Care is emerging in prominence, driven by the need for swift interventions in hospital settings where pressure ulcers can develop rapidly. With the rising incidence of hospital-acquired pressure ulcers, Acute Care facilities are investing in advanced treatment options and training for healthcare providers, making it a vital and fast-growing area within the market.

## Regional Market Share Analysis

The Pressure Ulcers Treatment Market is witnessing steady growth across its region. North America holds a significant position in this market, valued at 1.37 USD Billion in 2024, reflecting its majority holding due to advanced healthcare infrastructure and increased prevalence of pressure ulcers. Europe follows closely with a valuation of 1.05 USD Billion in 2024, propelled by rising awareness and support for pressure ulcer management.The Asia Pacific (APAC) region, valued at 0.6 USD Billion in 2024, showcases emerging opportunities owing to expanding healthcare facilities and populations requiring management for pressure ulcers.

Meanwhile, South America and the Middle East Africa (MEA) segments are relatively smaller, valued at 0.07 USD Billion and 0.08 USD Billion respectively in 2024, indicating growth potential but lower demand compared to their counterparts. The market growth in these regions is influenced by enhancing healthcare policies, product innovations, and an increasing aging population requiring effective treatment for pressure ulcers, driving the overall trajectory of the Pressure Ulcers Treatment Market revenue.

## Competitive Benchmarking

The Pressure Ulcers Treatment Market is characterized by a highly competitive landscape, driven by the increasing prevalence of pressure ulcers among patients, especially in long-term care settings like nursing homes and among bedridden patients. Growing awareness of effective treatment solutions alongside advancements in medical technology has led to numerous companies vying for market share. The market compositions include various treatments ranging from dressings and topical agents to surgical interventions that aim to prevent, manage, and heal pressure ulcers effectively. Regulatory approvals and collaborations with healthcare facilities present significant opportunities for innovation and diversification of product offerings, enhancing the competitive dynamics within the market.ConvaTec stands out as a key player in the Pressure Ulcers Treatment Market, leveraging its extensive expertise in advanced wound care technologies. The company's strengths lie in its diversified portfolio of wound care products, including high-quality dressings designed specifically for pressure ulcers. ConvaTec’s commitment to research and development fosters a continuous flow of innovative solutions, enhancing its market presence. Additionally, the company has established a strong global footprint through strategic partnerships and collaborations with healthcare professionals, ensuring its products meet the evolving needs of patients and providers alike. The brand’s reputation for product efficacy has cultivated lasting relationships with healthcare providers, further solidifying its competitive advantage in the market.Tegaderm focuses on providing innovative solutions for wound healing, specifically within the Pressure Ulcers Treatment Market, harnessing advanced materials to facilitate moisture management and promote healing. Known for its transparent film dressings, Tegaderm enhances visibility of the wound site while providing a protective barrier against external contaminants. The product line's adaptability enables use across various care settings and patient populations, which makes it a versatile choice for clinicians. Tegaderm's commitment to quality and efficacy, along with a dedicated approach to meeting patient needs, positions it favorably in the market. The continuous emphasis on consumer education and training for medical professionals regarding proper wound management further strengthens its position, allowing Tegaderm to remain competitive amidst a growing field.

## Recent News & Developments

- **Q2 2024: Smith+Nephew launches new PICO 7Y [negative pressure wound therapy](https://www.marketresearchfuture.com/reports/negative-pressure-wound-therapy-market-6514) system in the US** Smith+Nephew announced the US launch of its PICO 7Y system, a new negative pressure wound therapy device designed to help treat pressure ulcers and other complex wounds. The device features extended wear time and improved portability for patients.
- **Q2 2024: Mölnlycke opens new $50 million wound care manufacturing facility in the US** Mölnlycke, a global leader in wound care, inaugurated a new manufacturing facility in the United States to expand production of advanced dressings for pressure ulcer treatment, aiming to meet growing demand in North America.
- **Q2 2024: Coloplast acquires Kerecis for $1.3 billion to expand wound care portfolio** Coloplast completed the acquisition of Kerecis, an Icelandic company specializing in fish-skin-based wound care products, strengthening its offerings in the pressure ulcer and chronic wound treatment market.
- **Q3 2024: FDA clears 3M’s new Tegaderm Advanced Foam Dressing for pressure ulcer management** The US Food and Drug Administration granted clearance to 3M for its Tegaderm Advanced Foam Dressing, designed to manage exudate and protect against pressure ulcers in at-risk patients.
- **Q3 2024: Convatec appoints Karim Bitar as new CEO to drive wound care innovation** Convatec announced the appointment of Karim Bitar as Chief Executive Officer, with a mandate to accelerate innovation and growth in the company’s wound and pressure ulcer care business.
- **Q3 2024: Medline and Hillrom announce partnership to co-develop smart support surfaces for pressure ulcer prevention** Medline and Hillrom entered a strategic partnership to jointly develop and commercialize advanced support surfaces with integrated sensors for early detection and prevention of pressure ulcers in hospital settings.
- **Q4 2024: Acelity launches new wound care education initiative for pressure ulcer prevention** Acelity, a leader in advanced wound care, launched a global education program aimed at training healthcare professionals in best practices for pressure ulcer prevention and treatment.
- **Q4 2024: Smith+Nephew receives CE mark for RENASYS EDGE negative pressure wound therapy system** Smith+Nephew announced it has received CE mark approval for its RENASYS EDGE system, expanding its portfolio of negative pressure wound therapy devices for pressure ulcer management in Europe.
- **Q1 2025: Urgo Medical secures €100 million funding to expand pressure ulcer treatment R&D** Urgo Medical raised €100 million in new funding to accelerate research and development of advanced wound care solutions, with a focus on pressure ulcer treatment technologies.
- **Q1 2025: Smith+Nephew acquires US-based wound care startup HealX for $200 million** Smith+Nephew acquired HealX, a US-based startup specializing in digital wound assessment tools, to enhance its digital health capabilities in pressure ulcer management.
- **Q2 2025: FDA approves Mölnlycke’s Mepilex Border Flex Lite for pressure ulcer prevention** The FDA approved Mölnlycke’s Mepilex Border Flex Lite, a new dressing designed to prevent and treat pressure ulcers, expanding the company’s advanced wound care portfolio in the US market.
- **Q2 2025: Coloplast opens new innovation center focused on pressure ulcer solutions in Denmark** Coloplast inaugurated a new innovation center in Denmark dedicated to developing next-generation products for pressure ulcer prevention and treatment.

## Report Scope

| MARKET SIZE 2024 | 3.169(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 3.272(USD Billion) |
| MARKET SIZE 2035 | 4.501(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.24% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Smith & Nephew (GB), Mölnlycke Health Care (SE), Hollister Incorporated (US), 3M Company (US), KCI Medical (US), Medtronic (IE), Convatec Group (GB), Acelity (US), Derma Sciences (US) |
| Segments Covered | Product Type, Treatment Method, End Users, Applications, Regional |
| Key Market Opportunities | Integration of advanced wound care technologies enhances treatment efficacy in the Pressure Ulcers Treatment Market. |
| Key Market Dynamics | Rising demand for advanced wound care products drives innovation and competition in the Pressure Ulcers Treatment Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Pressure Ulcers Treatment Market by 2035?**
A: The market is projected to reach approximately 4.501 USD Billion by 2035.

**Q: What was the market valuation of the Pressure Ulcers Treatment Market in 2024?**
A: The market valuation was 3.169 USD Billion in 2024.

**Q: What is the expected CAGR for the Pressure Ulcers Treatment Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 3.24%.

**Q: Which product type segment is anticipated to show significant growth in the Pressure Ulcers Treatment Market?**
A: The Dressings segment, valued at 1.25 USD Billion in 2025, is anticipated to show significant growth.

**Q: What are the key players in the Pressure Ulcers Treatment Market?**
A: Key players include Smith & Nephew, Mölnlycke Health Care, and 3M Company, among others.

**Q: How does the Homecare Settings segment compare to Hospitals in terms of market valuation?**
A: In 2025, the Homecare Settings segment is projected to be valued at 1.2 USD Billion, compared to 1.8 USD Billion for Hospitals.

**Q: What treatment method segment is expected to have the highest valuation in 2025?**
A: The Conservative treatment method segment is expected to have the highest valuation at 1.6 USD Billion in 2025.

**Q: What is the projected valuation for the Wound Care Devices segment in 2025?**
A: The Wound Care Devices segment is projected to be valued at 1.0 USD Billion in 2025.

**Q: Which application segment is expected to grow the most by 2035?**
A: The Rehabilitative Care application segment is expected to grow significantly, reaching 1.651 USD Billion by 2035.

**Q: What is the anticipated market trend for the Pressure Ulcers Treatment Market in the coming years?**
A: The market trend suggests steady growth, driven by advancements in treatment technologies and increasing awareness.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/pressure-ulcers-treatment-market-43369*